Rizatriptan Benzoate (Rizatriptan Benzoate) (Tablet) 5 mg/1

Rizatriptan benzoate 5 mg tablets are used to relieve migraine headaches. This prescription medication belongs to a class of drugs known as triptans. It works by narrowing blood vessels in the brain to ease pain. Find fast-acting migraine relief options here.

Strength

5 mg/1

Manufacturer / TM Owner

Panacea Biotec Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rizatriptan benzoate 5 mg tablets are commonly used to treat acute migraine headaches with or without aura in adults. It is designed to reduce symptoms such as throbbing pain, nausea, and sensitivity to light and sound. People often ask, 'what is rizatriptan benzoate 5 mg used for?' to address sudden migraine attacks. This medication is not intended for preventive migraine treatment.

Side Effects

When taken as directed, rizatriptan benzoate 5 mg tablets can help reduce the intensity of migraine pain within 30 minutes to 2 hours. Some users report feeling relief from associated symptoms like nausea or light sensitivity. Effects may vary, and not everyone experiences immediate or complete relief.

Precautions & Warnings

Store rizatriptan benzoate 5 mg tablets at room temperature away from moisture and heat. Keep this medication out of reach of children and pets. Avoid exposing it to extreme temperatures or direct sunlight. If the packaging is damaged or the tablets appear discolored, do not use them.

Avoid Interactions

Rizatriptan benzoate may interact with other medications, especially those used for depression or high blood pressure. Combining it with alcohol or certain herbal supplements could increase side effects. Always inform your healthcare provider about all medications and supplements you are taking before using rizatriptan benzoate.

Frequently Asked Questions

Effects typically begin within 30 minutes to 2 hours after taking the tablet.

No, rizatriptan benzoate is only for treating acute migraine attacks, not prevention.

Consult a healthcare provider if the medication does not provide relief, as alternative treatments may be needed.

It may be used with other pain relievers, but consult a healthcare provider to avoid potential interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.